• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-GlcNAc 转移酶通过响应 CDK9 抑制作用维持代谢内稳态。

O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition.

机构信息

Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.

Patrick G Johnston Centre for Cancer Research, Queen's University, Belfast BT9 7AE, United Kingdom.

出版信息

Glycobiology. 2022 Aug 18;32(9):751-759. doi: 10.1093/glycob/cwac038.

DOI:10.1093/glycob/cwac038
PMID:35708495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9387508/
Abstract

Co-targeting of O-GlcNAc transferase (OGT) and the transcriptional kinase cyclin-dependent kinase 9 (CDK9) is toxic to prostate cancer cells. As OGT is an essential glycosyltransferase, identifying an alternative target showing similar effects is of great interest. Here, we used a multiomics approach (transcriptomics, metabolomics, and proteomics) to better understand the mechanistic basis of the combinatorial lethality between OGT and CDK9 inhibition. CDK9 inhibition preferentially affected transcription. In contrast, depletion of OGT activity predominantly remodeled the metabolome. Using an unbiased systems biology approach (weighted gene correlation network analysis), we discovered that CDK9 inhibition alters mitochondrial activity/flux, and high OGT activity is essential to maintain mitochondrial respiration when CDK9 activity is depleted. Our metabolite profiling data revealed that pantothenic acid (vitamin B5) is the metabolite that is most robustly induced by both OGT and OGT+CDK9 inhibitor treatments but not by CDK9 inhibition alone. Finally, supplementing prostate cancer cell lines with vitamin B5 in the presence of CDK9 inhibitor mimics the effects of co-targeting OGT and CDK9.

摘要

靶向 O-连接 N-乙酰氨基葡萄糖转移酶(OGT)和转录激酶细胞周期蛋白依赖性激酶 9(CDK9)的联合抑制对前列腺癌细胞具有细胞毒性。由于 OGT 是一种必需的糖基转移酶,因此寻找具有相似作用的替代靶标非常重要。在这里,我们使用多组学方法(转录组学、代谢组学和蛋白质组学)来更好地理解 OGT 和 CDK9 抑制联合致死的机制基础。CDK9 抑制优先影响转录。相比之下,OGT 活性的耗竭主要重塑了代谢组。使用无偏的系统生物学方法(加权基因相关网络分析),我们发现 CDK9 抑制改变了线粒体的活性/通量,并且当 CDK9 活性被耗尽时,高 OGT 活性对于维持线粒体呼吸是必需的。我们的代谢物分析数据表明,泛酸(维生素 B5)是最受 OGT 和 OGT+CDK9 抑制剂处理诱导的代谢物,但不受 CDK9 抑制剂单独作用的影响。最后,在 CDK9 抑制剂存在的情况下,用维生素 B5 补充前列腺癌细胞系可以模拟联合靶向 OGT 和 CDK9 的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/c3969a38df7c/cwac038f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/b663a364ea43/cwac038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/487d5b860459/cwac038f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/a1063b635509/cwac038f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/c3969a38df7c/cwac038f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/b663a364ea43/cwac038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/487d5b860459/cwac038f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/a1063b635509/cwac038f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909d/9387508/c3969a38df7c/cwac038f4.jpg

相似文献

1
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition.O-GlcNAc 转移酶通过响应 CDK9 抑制作用维持代谢内稳态。
Glycobiology. 2022 Aug 18;32(9):751-759. doi: 10.1093/glycob/cwac038.
2
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.O-GlcNAc 转移酶抑制使前列腺癌细胞依赖 CDK9。
Mol Cancer Res. 2020 Oct;18(10):1512-1521. doi: 10.1158/1541-7786.MCR-20-0339. Epub 2020 Jul 1.
3
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.O-GlcNAc 转移酶将 MRE11 与转录活跃的染色质连接起来,以抑制 DNA 损伤。
J Biomed Sci. 2022 Feb 14;29(1):13. doi: 10.1186/s12929-022-00795-1.
4
Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.鉴定一种基于二酮哌嗪的 O-GlcNAc 转移酶抑制剂,使肝癌对 CDK9 抑制敏感。
FEBS J. 2023 Sep;290(18):4543-4561. doi: 10.1111/febs.16877. Epub 2023 Jun 5.
5
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.高水平的 OGT 活性对于 MYC 驱动的前列腺癌细胞增殖是必需的。
Theranostics. 2019 Apr 12;9(8):2183-2197. doi: 10.7150/thno.30834. eCollection 2019.
6
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.抑制O-连接的N-乙酰葡糖胺转移酶活性可重编程前列腺癌细胞代谢。
Oncotarget. 2016 Mar 15;7(11):12464-76. doi: 10.18632/oncotarget.7039.
7
Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.O-链接β-N-乙酰葡萄糖胺转移酶在前列腺癌侵袭、血管生成和转移中的关键作用。
J Biol Chem. 2012 Mar 30;287(14):11070-81. doi: 10.1074/jbc.M111.302547. Epub 2012 Jan 24.
8
CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation.CDK9 抑制诱导代谢转换,使前列腺癌细胞依赖脂肪酸氧化。
Neoplasia. 2019 Jul;21(7):713-720. doi: 10.1016/j.neo.2019.05.001. Epub 2019 May 28.
9
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.O-GlcNAc 转移酶整合代谢途径来调节人前列腺癌细胞中 c-MYC 的稳定性。
Cancer Res. 2013 Aug 15;73(16):5277-87. doi: 10.1158/0008-5472.CAN-13-0549. Epub 2013 May 29.
10
Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).两种必需营养素敏感酶之间的串扰:O-连接的 N-乙酰氨基葡萄糖转移酶(OGT)和 AMP 激活的蛋白激酶(AMPK)。
J Biol Chem. 2014 Apr 11;289(15):10592-10606. doi: 10.1074/jbc.M113.523068. Epub 2014 Feb 21.

引用本文的文献

1
Dynamic O-GlcNAcylation and phosphorylation attract and expel proteins from RNA polymerase II to regulate mRNA maturation.动态的O-连接N-乙酰葡糖胺化和磷酸化作用吸引并驱离RNA聚合酶II上的蛋白质,从而调控信使核糖核酸的成熟。
J Biomed Sci. 2025 Apr 4;32(1):39. doi: 10.1186/s12929-025-01135-9.
2
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium.前列腺癌雄激素受体研究的新兴前沿领域:第二届国际雄激素受体研讨会的见解
J Exp Clin Cancer Res. 2024 Jul 17;43(1):194. doi: 10.1186/s13046-024-03125-5.
3
Roles of O-GlcNAcylation in Mitochondrial Homeostasis and Cardiovascular Diseases.

本文引用的文献

1
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.O-GlcNAc 转移酶将 MRE11 与转录活跃的染色质连接起来,以抑制 DNA 损伤。
J Biomed Sci. 2022 Feb 14;29(1):13. doi: 10.1186/s12929-022-00795-1.
2
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.抑制 CDK9 活性会损害前列腺癌细胞中的全局剪接。
RNA Biol. 2021 Nov 12;18(sup2):722-729. doi: 10.1080/15476286.2021.1983287. Epub 2021 Sep 30.
3
Prostate cancer.前列腺癌。
O-连接的N-乙酰葡糖胺化修饰在维持线粒体稳态及心血管疾病中的作用
Antioxidants (Basel). 2024 May 6;13(5):571. doi: 10.3390/antiox13050571.
4
Castration-resistant prostate cancer cells are dependent on the high activity of CDK7.去势抵抗性前列腺癌细胞依赖于 CDK7 的高活性。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5255-5263. doi: 10.1007/s00432-022-04475-3. Epub 2022 Nov 18.
Lancet. 2021 Sep 18;398(10305):1075-1090. doi: 10.1016/S0140-6736(21)00950-8. Epub 2021 Aug 6.
4
Metabolic reprogramming in prostate cancer.前列腺癌中的代谢重编程。
Br J Cancer. 2021 Oct;125(9):1185-1196. doi: 10.1038/s41416-021-01435-5. Epub 2021 Jul 14.
5
CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism.CDK9抑制剂通过抑制c-Myc介导的糖酵解代谢诱导B细胞急性淋巴细胞白血病细胞凋亡。
Front Cell Dev Biol. 2021 Mar 4;9:641271. doi: 10.3389/fcell.2021.641271. eCollection 2021.
6
O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?O-连接的 N-乙酰氨基葡萄糖转移酶——辅助因子还是全能致癌基因?
Mol Cancer Res. 2021 Apr;19(4):555-564. doi: 10.1158/1541-7786.MCR-20-0926. Epub 2021 Jan 20.
7
B Vitamins and Their Role in Immune Regulation and Cancer.B 族维生素及其在免疫调节和癌症中的作用。
Nutrients. 2020 Nov 4;12(11):3380. doi: 10.3390/nu12113380.
8
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.O-GlcNAc 转移酶抑制剂激活他莫昔芬耐药乳腺癌细胞中的肿瘤抑制基因表达。
Sci Rep. 2020 Oct 12;10(1):16992. doi: 10.1038/s41598-020-74083-z.
9
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.O-GlcNAc 转移酶抑制使前列腺癌细胞依赖 CDK9。
Mol Cancer Res. 2020 Oct;18(10):1512-1521. doi: 10.1158/1541-7786.MCR-20-0339. Epub 2020 Jul 1.
10
Tumour metabolism and its unique properties in prostate adenocarcinoma.前列腺腺癌中的肿瘤代谢及其独特特性。
Nat Rev Urol. 2020 Apr;17(4):214-231. doi: 10.1038/s41585-020-0288-x. Epub 2020 Feb 28.